Applied DNA Sciences (APDN) Tops Q3 EPS by 417c

Applied DNA Sciences (NASDAQ: APDN) reported Q3 EPS of $0.47, $4.17 better than the analyst estimate of ($3.70). Revenue for the quarter came in at $800 thousand versus the consensus estimate of $1.18 million.

For earnings history and earnings-related data on Applied DNA Sciences (APDN) click here.

You May Also Be Interested In

• DA Davidson Downgrades eXp World Holdings (AGNT) to Neutral
• Coca-Cola Europacific Partners launches second €500mn share buyback tranche
• Pepsico (PEP) PT Lowered to $144 at Barclays